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Abstract 
Motivation: Protein complexes play important roles in cellular functions. Many protein complexes have been identified by 
computational and purification methods so far. In which, cellular functions of protein complexes were well annotated; however, 
their roles in term of causing disease were not paid enough attention. Therefore, we here propose a method to identify 
associations between protein complexes and diseases.  
Results: To identify associations between diseases and protein complexes, we first constructed a protein complex network where 
two protein complexes are connected by shared genes. And then, we apply random walk with restart (RWR) algorithm on that 
network to rank candidate protein complexes based on their relative importance to known disease protein complexes. A leave-
one-out cross-validation method was used to assess the performance of the method. As a result, the performance in term of area 
under the ROC curve (AUC) was archived at a relative high value (> 0.96). We tested our method with breast cancer and selected 
top 20 highly ranked protein complexes. Interestingly, ten of the selected protein complexes were evidenced to be associated with 
breast cancer. 
 
© 2013 The Authors. Published by Elsevier B.V. 
Selection and peer-review under responsibility of the Program Committee of CSBio2013. 
Keywords: protein complex; disease; network-based method; breast cancer. 
 
 
* Corresponding author. Tel.: +82 52 259 2728; fax: +82 52 259 1687. 
E-mail address: hauldhut@gmail.com; kwonyk@ulsan.ac.kr. 
Available online at www.sciencedirect.com
 2013 The Authors. Published by Elsevier B.V.
Selection and p er-review unde  respons bility of the Program Committee of CSBio2013 
Open access under CC BY-NC-ND license.
Open access under CC BY-NC-ND license.
16   Duc-Hau Le et al. /  Procedia Computer Science  23 ( 2013 )  15 – 23 
1. Introduction 
The interactions among proteins play important roles in cellular functions. Proteins linked by non-covalent 
interactions form protein complexes which have specific biological functions. There have been many methods 
proposed to identify protein complexes from protein interaction network1 and affinity purification-mass 
spectrometry experiments2. During the detection process, cellular functions of protein complexes were well 
identified; however, their roles in term of causing disease were not paid enough attention. Indeed, in a protein 
complex database, CORUM3 released in February 2012, there were 2,867 protein complexes and all of them were 
well functionally annotated and categorized; however, only 178 cases had comment on their association with 
diseases.    
The interactions among proteins in protein interaction network and protein complexes do not only provide a 
better understanding of cellular functions, but they also improve our knowledge about human diseases. Indeed, past 
studies showed that mutations in multiple proteins that form a protein complex may lead to the same disease 
phenotype. Therefore, protein complexes were used to predict phenotypic effects of gene mutation. This task has 
important applications in elucidating how genotype determines phenotype and in identifying human disease genes4. 
Recently, a propagation method on protein interaction network has been proposed to associate genes and protein 
complexes with diseases5. However, the protein complexes identified in that study may not precise since they were 
generated from densely connected subsets of ranked proteins; therefore, the formation of such protein complexes is 
biased to shared topological properties of protein interaction network between their components rather than similar 
functional annotations. The associations between protein complexes and diseases were also unveiled by employing 
modularity of a human disease-related system including protein complexes and drugs6. However, the main outcome 
of that study is to reveal new polypharmacological properties. On the other hand, in the study7, a global protein 
complex network was constructed using existing human protein complexes and protein interaction network. After 
that, a network propagation method on that protein complex network along with a phenotypic similarity network 
was used to identify novel gene-phenotype associations. As a result, that method outperformed other methods which 
solely based on a human protein interaction network and phenotypic similarity network8,9. Taken together, this 
studies indicate that the protein complex contain disease-related information which aids prediction of novel disease-
gene associations. However, identification of novel disease-protein complex associations was not paid enough 
attention. 
In this study, we proposed a network-based method on protein complex network to identify novel disease-protein 
complex associations. First, we constructed a human protein complex network where each node is a protein complex 
and two protein complexes are connected if they share at least one protein. Second, we collected a set of known 
disease protein complexes, where a protein complex is known to be associated with a disease if there exists a known 
association between the disease and a gene which encodes a protein belonging to that complex. Third, we apply a 
random walk with restart (RWR) algorithm on the protein complex network to rank candidate protein complexes 
based on their relative importance to known disease protein complexes. The performance of our method was tested 
on 135 diseases using a leave-one-out cross-validation method. As a result, relative high AUC (area under the curve) 
values (>0.96) were archived and stable irrespective of changing a model parameter. This indicates that our method 
is suitable for identification of disease-protein complex associations. A case study on breast cancer was performed. 
As a result, ten out of top 20 highly ranked protein complexes were evidenced to be associated to breast cancer. 
2. Materials and Methods 
2.1. Databases of Protein complexes and Disease-gene associations 
First, we use protein complexes from CORUM3, a manually annotated protein complex database of mammalian 
organisms. Annotation includes protein complex function, localization, subunit composition and literature 
references. We obtained only 1,846 human protein complexes out of 2,867 in total.     
Second, to construct known disease-protein complex associations, we obtained 622 diseases and their associated 
genes from10. These diseases are identified by ICD-9-CM code10. 
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2.2. Construction of disease protein complex associations and protein complex network
Mutations in multiple proteins that form a protein complex or a pathway may lead to the same disease. To our 
knowledge, there is no standard database of disease-protein complex associations in the public except 178 cases
among 2,867 protein complexes in CORUM3 (released in February 2012) having a comment on their association 
with diseases. Therefore, to construct disease and protein complex associations, we defined such an association as
follow: a protein complex is associated with a disease if at least one of its subunit (i.e., protein) is associated to the
disease. Based on this definition of association and databases of protein complexes, disease-gene associations, we
obtained 139 diseases and their associated protein complexes.  
To construct protein complex network where each node is a protein complex, we defined an interaction between
two protein complexes as follow: two protein complexes are interacted with each other if they share at least one
protein, and a weight of the interaction is number of the shared proteins normalized by number of proteins of smaller
protein complex. Therefore, the weight of each interaction varies in range (0, 1] (Figure 1 showed an illustrative
example of construction of a protein complex interaction). Based on this definition and database of protein 
complexes, we constructed a protein complex network including 1,724 nodes and 20,939 interactions. By taking
only largest connected component, we finally obtained a protein complex network consisting of 1,579 nodes and
20,702 interactions.
Fig. 1. An illustrative example of construction of a protein complex interaction. Protein complexes 13S condensing and DNA ligase IV-condensin
compose of five and three proteins, respectively. Interaction between these two protein complexes is specified by two shared proteins and its
weight is the number of shared proteins divided by three (i.e., number of proteins involved in a smaller protein complex, DNA ligase IV-
condensin).
2.3. Definitions of network parameters
Let us assume that a protein complex network G(V, E) is a connected and weighted graph with a set of nodes
V={v1, v2 vN} and a set of links E={(vi, vj)| vi, vj V}. We defined a set of network parameters:
Node degree of a node vi is the number of links connecting to vi.
Network density is the ratio between number of interactions and number of all possible interactions
between all nodes in the network.
Network diameter is the largest number of links connecting two nodes.
Network radius is the minimum distance between nodes in the network.
Clustering coefficient of a node vi is the ratio between the number of edges among the neighbors of vi
and the maximum number of edges that could possibly exist between the neighbors of vi. This parameter 
measures degree to which nodes in a graph tend to cluster together and has a value in a range [0, 1].
Network centralization is a value ranging in [0, 1] and indicates structure of a network. A higher value
means structure of the network closer to a star.
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2.4. Random walk with restart algorithm 
RWR is a variant of the random walk and it mimics a walker that moves from a current node to a randomly 
selected adjacent node or goes back to source nodes (also called seed nodes) with a probability ( ). Given a 
connected weighted graph G(V, E) with a set of nodes V={v1, v2 N} and a set of links E={(vi, vj)| vi, vj V}, a set 
of source nodes S V and a N N RWR-guiding adjacency matrix W, RWR can be formally described as follows:  
 
pt+1 = (1- W pt + p0 
 
where pt is a N 1 probability vector of |V| nodes at a time step t of which the ith element represents the probability 
of the walker being at node vi V, and p0 is the N 1 initial probability vector where the value of an element 
corresponding to a non-source node or a source node is zero or 1/|S|, respectively. In the case that an unweighted 
graph is given, it can be easily transformed into a weighted graph by assigning the same arbitrary weight to all 
interactions. The RWR-guiding adjacency matrix W is represented by a column-normalized matrix and thus (W)ij, 
the (i, j) element in W, denotes a probability with which a walker at vi moves to vj among V\{vi}.  
In this study, RWR was used to prioritize candidate protein complexes from among protein complexes that have not 
been associated with a disease. Thus, the set of source nodes (S) consists of the protein complexes known to be 
associated with disease. All protein complexes in the network are eventually ranked according to the steady-state 
probability vector p , which is obtained by repeating the iterations until ||pt+1-pt||<10-6 in this study. 
2.5. Performance Evaluation 
Prioritization performance was assessed through the leave-one-out cross-validation process. Let us assume that a 
protein complex network G(V, E), a set of known disease protein complexes (D V) and a set of candidate protein 
complexes (C) are given. A protein complex s D is held out for validation and the remaining disease protein 
complexes are specified to a set of source nodes (i.e., S=D\{s}). The RWRA-guiding adjacency matrix W was 
constructed with the protein complex network (G), and then the RWR algorithm was used to prioritize all the 
candidate protein complexes. This process was repeated by setting every s D to a held-out protein complex. For a 
reliable performance comparison, we drew the receiver operating characteristic (ROC) curves and computed the 
area under the curve (AUC) based on the rank of held-out protein complex s in set C {s}. More specifically, given 
a threshold , we counted TP (true positives), FN (false negatives), FP (false positives), and TN (true negatives), 
which were formally defined as following: 
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where rank(s), rank(c) and I s, the rank of a candidate protein complex c out of the set C {s} 
and the indicator function, respectively. Then, we defined sensitivity and (1-specificity) as follows:  
 
FNTP
TPysensitivit
  and   TNFP
FPyspecificit1
. 
 
By varying  from one to the number of protein complexes in the set C {s}, the relationship between sensitivity and 
(1-specificity) was plotted. The ROC curve is the curve constructed based on those pairs of values, and the AUC is 
the area under the ROC curve. In this study, we considered candidate protein complex set as all protein complexes 
that are not known to be associated with the disease (i.e., V\D) in G. 
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3. Results 
3.1. Human protein complex network 
Study of topological properties of protein complex network is important, since the connections in the network not 
only reflect physical interactions among protein complexes, but may also represent common regulation, 
localization11. However, the investigation of a protein complex network has not been fully studies except a study for 
Saccharomyces cerevisiae 12. 
In this section, we analyze the human protein complex network (see Materials and Methods). To this end, we 
employed Network Analyzer tool13, which is a Cytoscape14 plugin for network analysis. As a result, the network is 
composed of 42 different connected components, where the largest contains 1,579 nodes (i.e., cover about 92% total) 
and 20,702 interactions (i.e., cover about 99% total). This very large connected component ensures stronger 
connectivity among most of the nodes of a network irrespective of the presence of other very small connected 
components. In addition, a high average number of neighbors 24.291, indicates that the protein complex network is 
highly connected but not densely populated since the network density is 0.014. Moreover, a high value of clustering 
coefficient 0.711 showed that nodes in the network tend to cluster together. However, this network structure is 
decentralized since network centralization value is 0.101. Besides that, network diameter and network radius are 
equal to 13 and 1, respectively, indicate that a maximal of 13 links and minimal of 1 link connecting a pair of 
protein complexes. The average shortest path length is 4.096 means that two protein complexes are connected by 
average number of 4 links. 
 
Fig. 2. Human protein complex network. 
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A more important topological property of a network is also assessed by node-degree distribution. This 
distribution specifies the model of the investigated network and therefore its evolution. For the human protein 
complex network, a node degree distribution was plotted in Figure 3 and a power law can be fitted to the points of 
the plot with correlation coefficient and determination coefficient (R-squared) are 0.677 and 0.765, respectively. 
These high coefficients depict that the protein complex network is a scale-free network. This property is shared with 
social networks and therefore, very important in selecting an algorithm for prioritization of protein complexes since 
many algorithms for both social and web networks have been successfully used for biological networks to prioritize 
PageRank15, PageRank with Priors, HITS with Priors and K-Step Markov16. In this study, we used a kind of network 
propagation algorithms, random walk with restart (RWR) which has been also used in many gene prioritization 
studies9,17-19, to prioritize disease candidate protein complexes. 
 
 
 
Fig. 3. Degree distribution is fitted by a power law equation y = axb (red line). In which, the vertical axis (y) is logarithm of number of protein 
complexes, the horizontal axis (x) is logarithm of degree, a = 667.5 and b = -1.215. 
 
3.2. Evaluation of prediction of disease associated protein complexes 
To assess performance of the proposed method, we used leave-one-out cross-validation method for each disease 
in the disease set (see Materials and Methods). After that, the performance of the proposed method is an average of 
AUC values of diseases. As a result, the proposed method achieved an AUC value of 0.975 at back-probability of 
0.5. To test whether the back-probability affects to the performance, we varied this value from 0.1 to 0.9. Figure 4 
showed that the performance is slightly changed. These relative high (> 0.96) and stable values of AUC indicate that 
our proposed method is independent of the model configuration and suitable to prioritize disease candidate protein 
complexes. For comparative evaluation, to our knowledge, there is no study directly focuses on identification of 
novel disease protein complexes, but protein complexes were used to aid prediction of novel disease-gene 
associations. However, based on networks of protein complexes (e.g., the human protein complex in this study), 
many other network-based algorithms can be applied to identify novel disease protein complexes. 
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Fig. 4. The performance of the proposed method. The back-probability was varied from 0.1 to 0.9 and the AUC values were little change and 
relative high (> 0.96). 
 
3.3. Identification of novel protein complexes associated with breast cancer 
Breast cancer, also called neoplasm of breast, is a complex disease and there were 25 genes associated to it as of 
200910. By associating these genes with human protein complexes, we found 85 protein complexes were known to 
be associated breast cancer (See Materials and Methods for definition of a known disease-protein complex 
association). After applying the RWR on those 85 training protein complexes and all others as candidates, we 
selected 20 highly ranked candidate protein complexes. By searching associations between genes coding proteins 
involved in those selected protein complexes with breast cancer on GeneRIF20 
(ftp://ftp.ncbi.nih.gov/gene/GeneRIF/generifs_basic.gz), we found that a total of 10 selected protein complexes 
containing genes coding proteins associated with breast cancer (see Table 1). Other protein complexes can be 
candidates for future validation.  
 
 
Table 1. Ten (bold rows) out of top 20 selected protein complexes are evidenced to be associated with breast cancer 
# Complex ID Complex Name 
Complex subunits 
(Gene Symbols) 
1 251 BCDX2 complex RAD51C, RAD51L1, RAD51L3, XRCC2 
2 260 RAD51B-RAD51C complex RAD51C, RAD51L1 
3 3849 TCL1(homotrimer) complex TCL1A 
4 5541 Ternary complex (TRAF2, FADD, TRADD) FADD, TRADD, TRAF2 
5 1155 Integrator-RNAPII complex CPSF3L, INTS1, INTS10, INTS12, INTS2, INTS3, INTS4, INTS5, INTS6, INTS7, INTS8, INTS9, POLR2A, POLR2B 
6 331 MRN complex (MRE11-RAD50-NBN complex) MRE11A, NBN, RAD50 
7 263 R/M complex (RAD50-MRE11 complex) MRE11A, RAD50 
8 627 MRN-TRRAP complex (MRE11A-RAD50-NBN-TRRAP complex) MRE11A, NBN, RAD50, TRRAP 
9 2218 MDC1-MRE11-RAD50-NBS1 complex MDC1, MRE11A, NBN, RAD50 
10 1189 DNA double-strand break end-joining complex LIG4, MRE11A, NBN, RAD50, XRCC4, XRCC5, XRCC6 
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11 619 MRE11A-RAD50-NBN-TRF2 complex MRE11A, NBN, RAD50, TERF2 
12 5197 PTIP-DNA damage response complex BLM, MRE11A, NBN, PAXIP1, RAD50, TP53BP1 
13 1153 Integrator complex CPSF3L, INTS1, INTS10, INTS12, INTS2, INTS3, INTS4, INTS5, INTS6, INTS7, INTS8, INTS9 
14 3168 DAXX-AXIN complex AXIN1, DAXX 
15 2968 Axin-SMAD3 complex AXIN1, SMAD3 
16 2052 BCL10 oligomer complex BCL10 
17 2053 BCL10-MALT1 complex BCL10, MALT1 
18 1078 MSH2-MSH6 complex MSH2, MSH6 
19 2051 MALT1 oligomer complex MALT1 
20 2101 IKKA-IKKB complex CHUK, IKBKB 
4. Conclusion 
In this study, we have proposed a RWR-based method to prioritize candidate disease protein complexes. The 
method was proposed based on an observed property of the constructed protein complex network (i.e., scale-free 
property). By testing the method on a set of diseases, the performance was archived at a relative high AUC value 
and stable with changing of back-probability parameter. Moreover, we also test the method on identification of 
novel protein complexes associated to breast cancer. The result showed that highly ranked protein complexes were 
evidenced with published literatures about their association to the disease of interest. Taken together, our method is 
reasonable for prioritization and identification of disease candidate protein complexes. This also promotes disease 
protein complex identification research area which has been not yet paid attention. In future study, other network-
based algorithms should be applied. In addition, the human protein network should be constructed in a more optimal 
way, where the weight of each interaction measures biologically statistically significant similarity between two 
protein complexes.  
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